通过代谢组学探索儿童哮喘的多样化临床表现
本研究在儿童哮喘管理计划(CAMP,n=953)和哥斯达黎加哮喘遗传流行病学研究(n=1,155)的儿童血浆样本中开展代谢组学分析,识别与22项临床特征(分属气道高反应性、特应性、肺功能、血嗜酸性粒细胞和血中性粒细胞五个表型域)相关的代谢物,并构建代谢组风险评分(MRS)以刻画各表型域的代谢过程。共发现154种独特代谢物与至少一项临床特征显著相关(q<0.05),组胺和犬尿氨酸跨四个表型域显著,7种代谢物跨三个表型域显著,并识别出各表型域特异性代谢物。域特异性MRS在不同代谢内表型间呈现不同模式,显示该方法可细化哮喘亚型。
要点
- 154种代谢物与22项儿童哮喘临床特征显著相关(q<0.05)。
- 组胺和犬尿氨酸跨四个表型域显著,7种代谢物跨三个表型域显著。
- 域特异性MRS可区分不同代谢内表型,有助细化哮喘亚型。
核心结论
- 代谢组能捕捉儿童哮喘临床表现的异质性,并构建有临床相关性的MRS以指导靶向治疗。
研究设计与样本
- 对CAMP研究(n=953)和哥斯达黎加哮喘遗传流行病学研究(n=1,155)儿童血浆样本进行代谢组学分析。
- 采用广义线性模型固定效应荟萃分析识别代谢物与22项临床特征的关联。
- 构建代谢组风险评分(MRS)总结各表型域的代谢过程。
主要发现
- 154种独特代谢物与至少一项临床特征显著相关(q<0.05)。
- 组胺和犬尿氨酸在四个表型域显著,7种代谢物在三个表型域显著。
- 域特异性代谢物包括n-油酰多巴胺(气道高反应性)、9-顺式视黄酸(肺功能)、磷脂酰胆碱(血嗜酸性粒细胞)和2-羟基丁酸(血中性粒细胞)。
- 域特异性MRS在不同代谢内表型间呈现不同模式。
临床怎么用
- 代谢组风险评分可用于细化儿童哮喘亚型,辅助识别特定代谢内表型以指导靶向治疗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Rationale: Pediatric asthma is heterogeneous, with varied clinical presentations and treatment responses. Metabolomic profiling may uncover shared and unique biological mechanisms across clinical traits that characterize pediatric asthma. Objectives: To characterize the varied clinical presentation of pediatric asthma by examining the metabolome's relationship with 22 clinical traits, categorized into five phenotypic domains: airway hyperresponsiveness, atopy, lung function, blood eosinophils, and blood neutrophils. Methods: Metabolomic profiling was conducted on plasma samples from children in the Childhood Asthma Management Program study (n = 953) and the Genetic Epidemiology of Asthma in Costa Rica Study (n = 1,155). We identified domain-specific and multidomain metabolites using a fixed-effect meta-analysis of generalized linear models between metabolites and 22 clinical traits. Metabolomic risk scores (MRSs) were developed to summarize the metabolic processes for each domain at the patient level. Measurements and Main Results: There were 154 unique metabolites significantly associated with at least one of 22 clinical traits (q < 0.05). Histamine and kynurenine were significant across four domains, whereas seven metabolites-12,13-diHOME, azelate, sebacate, PC(P-36:0)/PC(O-36:1), taurine, nudifloramide, and niacinamide-were significant across three. Notable domain-specific metabolites include n-oleoyl dopamine for airway hyperresponsiveness, 9-cis-retinoic acid for lung function, phosphatidylcholines for blood eosinophils, and 2-hydroxybutyric acid for blood neutrophils. Domain specific MRS exhibited distinct patterns across the metaboendotypes, highlighting the ability of this approach to refine asthma subtypes. Conclusions: This study demonstrated the power of the metabolome to capture the heterogeneity in the clinical presentation of pediatric asthma and to develop clinically relevant MRSs that inform our understanding of specific metabotypes to guide targeted treatment approaches.
引用
- Mendez KM, Kachroo P, Prince N, et al. Exploring the Varied Clinical Presentation of Pediatric Asthma through the Metabolome. Am J Respir Crit Care Med. 2025. PMID: 39965055. doi:10.1164/rccm.202407-1382OC
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。